Cumberland Advisors Inc Pfizer Inc Transaction History

Cumberland Advisors Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$45.75 - $56.69 $310,917 - $385,265	-6,796 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$41.32 - $61.25 $41,320 - $61,250	-1,000 Reduced 12.83%	6,796 $401,000
Q3 2021 Oct 26, 2021	BUY	$39.25 - $50.42 $20,684 - $26,571	527 Added 7.25%	7,796 $335,000
Q2 2021 Jul 12, 2021	SELL	$35.91 - $40.68 $23,341 - $26,442	-650 Reduced 8.21%	7,269 $285,000
Q1 2021 Apr 20, 2021	SELL	$33.49 - $37.77 $418,625 - $472,125	-12,500 Reduced 61.22%	7,919 $287,000
Q4 2020 Jan 20, 2021	SELL	$33.47 - $42.56 $49,569 - $63,031	-1,481 Reduced 6.76%	20,419 $752,000
Q2 2020 Jul 20, 2020	SELL	$30.12 - $36.54 $30,120 - $36,540	-1,000 Reduced 4.37%	21,900 $716,000
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $466,267 - $666,195	17,250 Added 305.31%	22,900 $747,000
Q4 2019 Jan 16, 2020	BUY	$32.92 - $37.36 $185,998 - $211,084	5,650 New	5,650 $221,000
Q3 2019 Oct 11, 2019	SELL	$32.49 - $42.13 $170,572 - $221,182	-5,250 Closed	0 $0
Q4 2018 Jan 08, 2019	BUY	$38.47 - $43.86 $201,967 - $230,265	5,250 New	5,250 $229,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cumberland Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Cumberland Advisors Inc with notifications on news.